Rafati, Sima <br/><br/>
Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation.  [electronic resource] 

 -  Vaccine  Jun 2002 
 - 2439-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(02)00189-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cysteine Endopeptidases--administration & dosage<br/>Female<br/>Interferon-gamma--biosynthesis<br/>Leishmania major--immunology<br/>Leishmaniasis--prevention & control<br/>Lymphocyte Activation--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Protozoan Vaccines--administration & dosage<br/>Recombinant Proteins--administration & dosage